bf/NASDAQ:SCYX_icon.png

NASDAQ:SCYX

SCYNEXIS, Inc.

  • Stock

USD

Last Close

0.60

06/11 22:16

Market Cap

74.43M

Beta: 2.16

Volume Today

26.36K

Avg: 1.90M

PE Ratio

2.18

PFCF: 1.72

OverviewFinancialsAPI

    Description

    SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including r...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -4-3-2-1122018-05-082020-05-112022-03-292023-08-142024-11-06

    Revenue (Estimate*)

    20M40M60M80M100M120M140M2018-05-082020-05-112022-03-292023-08-142024-11-06

    *Estimate based on analyst consensus